These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 12358334)
1. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Emelyanov A; Fedoseev G; Krasnoschekova O; Abulimity A; Trendeleva T; Barnes PJ Eur Respir J; 2002 Sep; 20(3):596-600. PubMed ID: 12358334 [TBL] [Abstract][Full Text] [Related]
2. Marine lipid fraction PCSO-524 (lyprinol/omega XL) of the New Zealand green lipped mussel attenuates hyperpnea-induced bronchoconstriction in asthma. Mickleborough TD; Vaughn CL; Shei RJ; Davis EM; Wilhite DP Respir Med; 2013 Aug; 107(8):1152-63. PubMed ID: 23660397 [TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus (Lyprinol). Halpern GM Allerg Immunol (Paris); 2000 Sep; 32(7):272-8. PubMed ID: 11094640 [TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and safety of Lyprinol, a patented extract from New Zealand green-lipped mussel (Perna Canaliculus) in patients with osteoarthritis of the hip and knee: a multicenter 2-month clinical trial. Cho SH; Jung YB; Seong SC; Park HB; Byun KY; Lee DC; Song EK; Son JH Eur Ann Allergy Clin Immunol; 2003 Jun; 35(6):212-6. PubMed ID: 12872680 [TBL] [Abstract][Full Text] [Related]
5. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group. Liu MC; Dubé LM; Lancaster J J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):859-71. PubMed ID: 8939149 [TBL] [Abstract][Full Text] [Related]
6. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Sandrini A; Ferreira IM; Gutierrez C; Jardim JR; Zamel N; Chapman KR Chest; 2003 Oct; 124(4):1334-40. PubMed ID: 14555563 [TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN12610000978066. Kean JD; Camfield D; Sarris J; Kras M; Silberstein R; Scholey A; Stough C Nutr J; 2013 Jul; 12():100. PubMed ID: 23866813 [TBL] [Abstract][Full Text] [Related]
8. Possible steroid-sparing effect in asthma of lyprinol, a shellfish lipid extract. Harbison SJ; Whitehouse MW Med J Aust; 2000 Nov; 173(10):560. PubMed ID: 11194748 [No Abstract] [Full Text] [Related]
9. Increased hydrogen peroxide and thiobarbituric acid-reactive products in expired breath condensate of asthmatic patients. Antczak A; Nowak D; Shariati B; Król M; Piasecka G; Kurmanowska Z Eur Respir J; 1997 Jun; 10(6):1235-41. PubMed ID: 9192922 [TBL] [Abstract][Full Text] [Related]
10. The Effects of PCSO-524®, a Patented Marine Oil Lipid derived from the New Zealand Green Lipped Mussel ( Shei RJ; Adamic EM; Chapman RF; Mickleborough TD Int J Exerc Sci; 2018; 11(3):669-680. PubMed ID: 29997731 [TBL] [Abstract][Full Text] [Related]
11. Marine lipids: overview "news insights and lipid composition of Lyprinol". Sinclair AJ; Murphy KJ; Li D Allerg Immunol (Paris); 2000 Sep; 32(7):261-71. PubMed ID: 11094639 [TBL] [Abstract][Full Text] [Related]
13. Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial. Kean JD; Sarris J; Scholey A; Silberstein R; Downey LA; Stough C Psychopharmacology (Berl); 2017 Feb; 234(3):403-420. PubMed ID: 27921139 [TBL] [Abstract][Full Text] [Related]
14. Anti-cyclooxygenase effects of lipid extracts from the New Zealand green-lipped mussel, Perna canaliculus. McPhee S; Hodges LD; Wright PF; Wynne PM; Kalafatis N; Harney DW; Macrides TA Comp Biochem Physiol B Biochem Mol Biol; 2007 Mar; 146(3):346-56. PubMed ID: 17197217 [TBL] [Abstract][Full Text] [Related]
15. Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness. Nathan RA; Minkwitz MC; Bonuccelli CM Ann Allergy Asthma Immunol; 1999 May; 82(5):497-503. PubMed ID: 10353583 [TBL] [Abstract][Full Text] [Related]
16. Inhaled glucocorticosteroids decrease hydrogen peroxide level in expired air condensate in asthmatic patients. Antczak A; Kurmanowska Z; Kasielski M; Nowak D Respir Med; 2000 May; 94(5):416-21. PubMed ID: 10868702 [TBL] [Abstract][Full Text] [Related]
17. Furan fatty acid as an anti-inflammatory component from the green-lipped mussel Perna canaliculus. Wakimoto T; Kondo H; Nii H; Kimura K; Egami Y; Oka Y; Yoshida M; Kida E; Ye Y; Akahoshi S; Asakawa T; Matsumura K; Ishida H; Nukaya H; Tsuji K; Kan T; Abe I Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17533-7. PubMed ID: 21972415 [TBL] [Abstract][Full Text] [Related]
18. Zileuton added to low-dose inhaled beclomethasone for the treatment of moderate to severe persistent asthma. O'Connor BJ; Löfdahl CG; Balter M; Szczeklik A; Boulet LP; Cairns CB Respir Med; 2007 Jun; 101(6):1088-96. PubMed ID: 17360171 [TBL] [Abstract][Full Text] [Related]
19. RCT of the effect of berryfruit polyphenolic cultivar extract in mild steroid-naive asthma: a cross-over, placebo-controlled study. Power S; Williams M; Semprini A; Munro C; Caswell-Smith R; Pilcher J; Holliday M; Fingleton J; Harper J; Hurst R; Weatherall M; Beasley R; Braithwaite I BMJ Open; 2017 Mar; 7(3):e013850. PubMed ID: 28320793 [TBL] [Abstract][Full Text] [Related]
20. Systematic review of a marine nutriceutical supplement in clinical trials for arthritis: the effectiveness of the New Zealand green-lipped mussel Perna canaliculus. Cobb CS; Ernst E Clin Rheumatol; 2006 May; 25(3):275-84. PubMed ID: 16220229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]